172 related articles for article (PubMed ID: 35752274)
1. The role of triggering receptor expressed on myeloid cells 2 in Parkinson's disease and other neurodegenerative disorders.
Schwarz H; Bässler S; Balta D; Socher E; Zunke F; Arnold P
Behav Brain Res; 2022 Sep; 433():113977. PubMed ID: 35752274
[TBL] [Abstract][Full Text] [Related]
2. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
[TBL] [Abstract][Full Text] [Related]
3. Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation－neglected multidimensional regulation of microglia.
Zhang X; Chen X; Zhang L; Sun Y; Liang Y; Li H; Zhang Y
Neurochem Int; 2023 Dec; 171():105639. PubMed ID: 37926352
[TBL] [Abstract][Full Text] [Related]
4. Microglia Mediated Neuroinflammation in Parkinson's Disease.
Isik S; Yeman Kiyak B; Akbayir R; Seyhali R; Arpaci T
Cells; 2023 Mar; 12(7):. PubMed ID: 37048085
[TBL] [Abstract][Full Text] [Related]
5. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
6. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
[TBL] [Abstract][Full Text] [Related]
7. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
8. Triggering Receptor Expressed on Myeloid Cells 2 Protects Dopaminergic Neurons by Promoting Autophagy in the Inflammatory Pathogenesis of Parkinson's Disease.
Huang W; Lv Q; Xiao Y; Zhong Z; Hu B; Yan S; Yan Y; Zhang J; Shi T; Jiang L; Li W; Lu G
Front Neurosci; 2021; 15():745815. PubMed ID: 34867158
[TBL] [Abstract][Full Text] [Related]
9. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias.
Shafi S; Singh A; Ibrahim AM; Alhajri N; Abu Izneid T; Pottoo FH
Eur J Neurosci; 2021 May; 53(10):3294-3310. PubMed ID: 33786894
[TBL] [Abstract][Full Text] [Related]
10. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
13. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.
Walter J
J Biol Chem; 2016 Feb; 291(9):4334-41. PubMed ID: 26694609
[TBL] [Abstract][Full Text] [Related]
14. Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases.
Han J; Wang M; Ren M; Lou H
Int J Neurosci; 2017 Apr; 127(4):368-375. PubMed ID: 27871212
[TBL] [Abstract][Full Text] [Related]
15. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.
Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H
FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707
[TBL] [Abstract][Full Text] [Related]
16. Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases.
Konishi H; Kiyama H
Front Cell Neurosci; 2018; 12():206. PubMed ID: 30127720
[TBL] [Abstract][Full Text] [Related]
17. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
18. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
[TBL] [Abstract][Full Text] [Related]
19. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
20. Glial phagocytic clearance in Parkinson's disease.
Tremblay ME; Cookson MR; Civiero L
Mol Neurodegener; 2019 Apr; 14(1):16. PubMed ID: 30953527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
